# Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

> **NCT06126419** · NA · RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 70 (estimated)

## Conditions studied

- Liver Dysfunction
- Liver Metastasis Colon Cancer
- Liver Regeneration

## Interventions

- **DRUG:** High-Dose Insulin Therapy

## Key facts

- **NCT ID:** NCT06126419
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-08
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126419, "Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06126419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*